Actemra 162 mg (Tocilizumab SOLUTION) 162 MG

ACTEMRA 162 MG is a subcutaneous solution containing tocilizumab, used for managing inflammatory conditions. This medication is designed to help reduce inflammation and improve symptoms.

Strength

162 MG

Pack Size

4 AUTOINJECTORS

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ACTEMRA 162 MG is primarily used for the treatment of inflammatory conditions. It works by targeting specific pathways in the body to reduce inflammation. This medication may be prescribed for conditions where inflammation causes significant discomfort or complications. What is ACTEMRA used for? It is often used in the management of autoimmune diseases and other inflammatory disorders.

Side Effects

Common effects of ACTEMRA 162 MG may include injection site reactions, such as redness or swelling. Some individuals might experience headaches or fatigue. These effects are generally mild and temporary. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Precautions & Warnings

ACTEMRA 162 MG should be handled with care. It is important to follow the prescribed dosage and administration instructions. This medication should be stored properly to maintain its effectiveness. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

ACTEMRA 162 MG may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with your healthcare provider. Alcohol and certain supplements may also interact with this medication, so it is advisable to avoid them unless approved by a healthcare professional.

Frequently Asked Questions

ACTEMRA 162 MG is used for managing inflammatory conditions by reducing inflammation in the body.

ACTEMRA 162 MG is administered subcutaneously using autoinjectors. Follow the instructions provided by your healthcare provider.

Common side effects may include injection site reactions, headaches, and fatigue. These effects are usually mild and temporary.

It is important to discuss all current medications with your healthcare provider to avoid potential interactions.

ACTEMRA 162 MG should be stored as per the instructions provided, typically in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.